These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 38361953)

  • 1. Unraveling lipid and inflammation interplay in cancer, aging and infection for novel theranostic approaches.
    Conde-Torres D; Blanco-González A; Seco-González A; Suárez-Lestón F; Cabezón A; Antelo-Riveiro P; Piñeiro Á; García-Fandiño R
    Front Immunol; 2024; 15():1320779. PubMed ID: 38361953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidomic and Membrane Mechanical Signatures in Triple-Negative Breast Cancer: Scope for Membrane-Based Theranostics.
    Dadhich R; Kapoor S
    Mol Cell Biochem; 2022 Nov; 477(11):2507-2528. PubMed ID: 35595957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipidomics-Paving the Road towards Better Insight and Precision Medicine in Rare Metabolic Diseases.
    Zandl-Lang M; Plecko B; Köfeler H
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipidomics in autoimmune diseases with main focus on systemic lupus erythematosus.
    Ferreira HB; Pereira AM; Melo T; Paiva A; Domingues MR
    J Pharm Biomed Anal; 2019 Sep; 174():386-395. PubMed ID: 31207360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipidomics applications for discovering biomarkers of diseases in clinical chemistry.
    Zhao YY; Cheng XL; Lin RC
    Int Rev Cell Mol Biol; 2014; 313():1-26. PubMed ID: 25376488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine.
    Cioccari L; Luethi N; Masoodi M
    Front Immunol; 2020; 11():599853. PubMed ID: 33324417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research advances in integrated theranostic probes for tumor fluorescence visualization and treatment.
    Xing J; Gong Q; Akakuru OU; Liu C; Zou R; Wu A
    Nanoscale; 2020 Dec; 12(48):24311-24330. PubMed ID: 33300527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.
    Butler LM; Perone Y; Dehairs J; Lupien LE; de Laat V; Talebi A; Loda M; Kinlaw WB; Swinnen JV
    Adv Drug Deliv Rev; 2020; 159():245-293. PubMed ID: 32711004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipidomic landscape in cancer: Actionable insights for membrane-based therapy and diagnoses.
    Agarwala PK; Aneja R; Kapoor S
    Med Res Rev; 2022 Mar; 42(2):983-1018. PubMed ID: 34719798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
    Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
    Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipidomic Network of Mild Cognitive Impairment from the Mayo Clinic Study of Aging.
    Wang X; Bui H; Vemuri P; Graff-Radford J; Jack CR; Petersen RC; Mielke MM
    J Alzheimers Dis; 2021; 81(2):533-543. PubMed ID: 33814434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging macrophages for cancer theranostics.
    Liu L; Li H; Wang J; Zhang J; Liang XJ; Guo W; Gu Z
    Adv Drug Deliv Rev; 2022 Apr; 183():114136. PubMed ID: 35143894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theranostics and metabolotheranostics for precision medicine in oncology.
    Bhujwalla ZM; Kakkad S; Chen Z; Jin J; Hapuarachchige S; Artemov D; Penet MF
    J Magn Reson; 2018 Jun; 291():141-151. PubMed ID: 29705040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic designs of biomaterials for precision medicine in cancer therapy.
    Kim H; Kwak G; Kim K; Yoon HY; Kwon IC
    Biomaterials; 2019 Aug; 213():119207. PubMed ID: 31136910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Platform Comparison of Untargeted and Targeted Lipidomics Approaches on Aging Mouse Plasma.
    Contrepois K; Mahmoudi S; Ubhi BK; Papsdorf K; Hornburg D; Brunet A; Snyder M
    Sci Rep; 2018 Dec; 8(1):17747. PubMed ID: 30532037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current theranostic approaches for metastatic cancers through hypoxia-induced exosomal packaged cargo.
    Singh M; Agarwal S; Agarwal V; Mall S; Pancham P; Mani S
    Life Sci; 2021 Dec; 286():120017. PubMed ID: 34619169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry-Enabled Precision Medicine.
    Gatalica Z; Feldman R; Vranić S; Spetzler D
    Cancer Treat Res; 2019; 178():111-135. PubMed ID: 31209843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids and Alzheimer's Disease.
    Kao YC; Ho PC; Tu YK; Jou IM; Tsai KJ
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging and inflammation: etiological culprits of cancer.
    Ahmad A; Banerjee S; Wang Z; Kong D; Majumdar AP; Sarkar FH
    Curr Aging Sci; 2009 Dec; 2(3):174-86. PubMed ID: 19997527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.